Treating Patients With Breast Cancer After Progression on Endocrine Therapy

home / case-based-roundtable-series / treating-patients-with-breast-cancer-after-progression-on-endocrine-therapy

This roundtable series explores therapies after progression on endocrine therapy in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer who have an ESR1 mutation,as discussed by key opinion leaders and participants at virtual live events.

Updates on SERD Trials for Metastatic Breast Cancer

Updates on SERD Trials for Metastatic Breast Cancer

Targeted Oncology Staff
March 17th 2023

Sara Hurvitz, MD, discusses recent updates for selective estrogen receptor degraders in the treatment of patients with metastatic breast cancer and how it has impacted clinical decisions.